FOCUS UNIVERSAL INC (FCUV)

US34417J1043 - Common Stock

0.97  +0.01 (+1.15%)

Premarket: 0.8292 -0.14 (-14.52%)

Fundamental Rating

2

Overall FCUV gets a fundamental rating of 2 out of 10. We evaluated FCUV against 126 industry peers in the Electronic Equipment, Instruments & Components industry. FCUV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FCUV is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

FCUV had negative earnings in the past year.
In the past year FCUV has reported a negative cash flow from operations.
In the past 5 years FCUV always reported negative net income.
In the past 5 years FCUV always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -66.96%, FCUV is doing worse than 89.26% of the companies in the same industry.
With a Return On Equity value of -76.61%, FCUV is not doing good in the industry: 82.64% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -66.96%
ROE -76.61%
ROIC N/A
ROA(3y)-54.77%
ROA(5y)-50.75%
ROE(3y)-73.71%
ROE(5y)-64.32%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for FCUV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

FCUV does not have a ROIC to compare to the WACC, probably because it is not profitable.
FCUV has less shares outstanding than it did 1 year ago.
The number of shares outstanding for FCUV has been increased compared to 5 years ago.
Compared to 1 year ago, FCUV has a worse debt to assets ratio.

2.2 Solvency

FCUV has an Altman-Z score of 46.07. This indicates that FCUV is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 46.07, FCUV belongs to the top of the industry, outperforming 98.35% of the companies in the same industry.
FCUV has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of FCUV (0.01) is better than 60.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 46.07
ROIC/WACCN/A
WACC10.32%

2.3 Liquidity

A Current Ratio of 7.82 indicates that FCUV has no problem at all paying its short term obligations.
FCUV's Current ratio of 7.82 is amongst the best of the industry. FCUV outperforms 90.08% of its industry peers.
FCUV has a Quick Ratio of 7.19. This indicates that FCUV is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of FCUV (7.19) is better than 91.74% of its industry peers.
Industry RankSector Rank
Current Ratio 7.82
Quick Ratio 7.19

3

3. Growth

3.1 Past

FCUV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.97%, which is quite good.
FCUV shows a decrease in Revenue. In the last year, the revenue decreased by -9.65%.
FCUV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.69% yearly.
EPS 1Y (TTM)19.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250.51%
Revenue 1Y (TTM)-9.65%
Revenue growth 3Y-14.44%
Revenue growth 5Y27.69%
Sales Q2Q%-76.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FCUV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FCUV!.
Industry RankSector Rank
Dividend Yield N/A

FOCUS UNIVERSAL INC

NASDAQ:FCUV (1/6/2025, 8:00:01 PM)

Premarket: 0.8292 -0.14 (-14.52%)

0.97

+0.01 (+1.15%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-15 2024-11-15/bmo
Earnings (Next)N/A N/A
Inst Owners3.85%
Inst Owner Change0%
Ins Owners54.01%
Ins Owner Change10.35%
Market Cap70.73M
Analysts0
Price TargetN/A
Short Float %0.03%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 92.28
P/FCF N/A
P/OCF N/A
P/B 12.99
P/tB 12.99
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.01
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -66.96%
ROE -76.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-54.77%
ROA(5y)-50.75%
ROE(3y)-73.71%
ROE(5y)-64.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.01%
Cap/Sales 1.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.82
Quick Ratio 7.19
Altman-Z 46.07
F-Score3
WACC10.32%
ROIC/WACCN/A
Cap/Depr(3y)16.1%
Cap/Depr(5y)37.16%
Cap/Sales(3y)4.93%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.65%
Revenue growth 3Y-14.44%
Revenue growth 5Y27.69%
Sales Q2Q%-76.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-60.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-55.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.53%
OCF growth 3YN/A
OCF growth 5YN/A